Top Abstract Purchase Related
Home
>
Node
>
Subnode

An approach to the safety management of ambulant cancer chemotherapy

Iwasa, M.; Hori, A.; Atsumi, S.; Kumaki, M.; Watanabe, M.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(Suppl 1): 4-6

2008

ISSN/ISBN: 0385-0684
PMID: 20443289
Document Number: 615128
As for ambulant cancer chemotherapy at Tokai University Hachioji Hospital, we have been employing computerized methods with electronic medical charts for a series of operations, such as receiving medication instructions by doctors, preparation of drugs, chemotherapy regimen-checks and quantitative calculations for admixtures of anticancer drugs. Additionally, we have introduced new features that print information such as chemical data needed for regimen-checks and doctors' answers to questions about prescriptions on the prescriptions of injections. The system is enabled by pharmacists accurately and effectively to check prescriptions of injections, to calculate the precise quantity for admixtures of drugs, and also to share information among pharmacists. It has contributed to the efficiency and medical safety of the ambulant cancer chemotherapy.

Document emailed within 1 workday
Secure & encrypted payments

Ohya, M.; Gohda, Y.; Sato, S.; Makishima, K.; Murakami, M. 2009: Role of pharmacists on the safety management of ambulatory cancer chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(Suppl 1): 57-59
Konstam, P.G. 1974: Tuberculosis of the spine: treatment by ambulant chemotherapy. A report of five cases Journal of the Royal College of Surgeons of Edinburgh 19(3): 179-181
Reinders, T.P.; Steinke, W.E. 1979: Pharmacist management of anticoagulant therapy in ambulant patients American Journal of Hospital Pharmacy 36(5): 645-648
Liu, G.-q.; Ding, H.-f.; Lu, X.-j.; Xu, M.; Xing, J.; Zhao, X.; Han, F.; Shang, Y.-h. 2012: The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy Zhonghua Nei Ke Za Zhi 51(3): 188-191
Ashcroft, B.; Eistein, M.; Boreham, N. 2000: Reducing error, improving safety. Systems approach to intrapartum risk management is important Bmj 321(7259): 508
Kitada, N.; Nishino, M.; Yasuda, J.; Morita, S.; Fujii, C.; Minegaki, T.; Kondoh, M.; Anami, S.; Takara, K.; Watari, M. 2009: Equalization of breast cancer chemotherapy at general hospital( Ii )-evaluation of safety in FEC and TC regimens Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(10): 1671-1675
Looney, W.B.; Goldie, J.H.; Little, J.B.; Hopkins, H.A.; Read, E.J.; Wittes, R. 1985: Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop Cancer Treatment Reports 69(7-8): 769-775
Ohta, K.; Dohden, K.; Morishita, M.; Hayashi, H.; Hattori, M.; Hosokawa, O.; Morita, M.; Kaizaki, Y.; Kiya, T. 2006: Clinical examination of safety and effectiveness of primary chemotherapy with CEF followed by docetaxel in preoperative breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(2): 199-202
Su, W.; Zhang, S.; Li, C.; Hao, X.; Zhang, J. 2015: Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 37(5): 379-382
Geisler, J.P.; Manahan, K.J.; Wiemann, M.C. 2004: Chemotherapy for ovarian cancer: an evidence-based approach Minerva Ginecologica 56(6): 539-545
Denny, W.A. 2001: Turning off growth signals in tumours: a new approach to cancer chemotherapy New Zealand Medical Journal 114(1125): 47-48
Karolak, E.; Bogusz, M. 2009: The Development of a Documented Integrated Management System (Quality and Health and Safety Management Systems) in Greater Poland Cancer Centre (Poland) Radiotherapy and Oncology 92: S233-S234
Felip, E. 2000: Neoadjuvant chemotherapy in non-small cell lung cancer: a standard approach? Tumori 86(5 Suppl 1: S51-S55
Bello, J.L.; Kariev, N.I.; Mainardi, J.V.; Betancourt, M.; Lage, A.; Barroso, M.C.; Alfonso, L. 1982: Experimental approach for the search of effective drug combination in cancer chemotherapy Neoplasma 29(1): 65-71
Bregetzer, J. 1978: The management of cancer chemotherapy Revue de l'Infirmiere 28(1): 5-7
Mori, A.; Hirose, T.; Tamura, A.; Kusaka, K.; Matsui, H.; Ohta, K. 2016: Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(6): 723-726
Xia, W.; Hu, Y.; Mou, T.; Chen, T.; Yu, J.; Li, G. 2014: Safety and efficacy of intraperitoneal hyperthermic perfusion chemotherapy following laparoscopic palliative resection for gastric cancer patients with peritoneal metastasis Zhonghua Wei Chang Wai Ke Za Zhi 17(11): 1087-1091
Yamamoto, N.; Tabei, T.; Inoue, K.; Takei, H.; Sato, N.; Yanagita, Y.; Fujisawa, T.; Fujii, H.; Saeki, T.; Kurosumi, M. 2010: Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 57-63
Swain, S.M.; Sorace, R.A.; Bagley, C.S.; Danforth, D.N.; Bader, J.; Wesley, M.N.; Steinberg, S.M.; Lippman, M.E. 1987: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer Cancer Research 47(14): 3889-3894
Markman, M. 1999: Intraperitoneal chemotherapy in the management of colon cancer Seminars in Oncology 26(5): 536-539